Gene-Tailored vitamins may shield Moms-to-Be from dangerous hypertension
NCT ID NCT04723836
First seen Oct 31, 2025 · Last updated May 24, 2026 · Updated 29 times
Summary
This study tests whether giving extra riboflavin (vitamin B2) and folate to pregnant women with a specific gene variant can prevent high blood pressure. About 2250 women in early pregnancy will be screened for the MTHFR gene, and those with the TT or CT variant will receive supplements or placebo until delivery. The goal is a simple, non-drug way to protect both mother and baby from pregnancy-related hypertension.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Letterkenny University Hospital
Letterkenny, Ireland
-
Northern Health and Social Care Trust
Coleraine, N.Ireland, BT52 1HS, United Kingdom
-
Western Health and Social Care Trust
Londonderry, N.Ireland, BT47 6SB, United Kingdom
Conditions
Explore the condition pages connected to this study.